Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Retinoids on CYP2D6 Activity in Pregnancy
NCT03117660Phase 1Completed
- Sponsor
- University of Washington
- Start
- Jul 2017
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by University of Washington. Primary endpoint: CYP2D6 activity: dextromethorphan metabolic ratio at 4 weeks. Started Jul 2017; status: completed.
Beyond the preview
Go deeper on NCT03117660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117660.